Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2013 ◽
Vol 43
(1)
◽
pp. 20-27
◽
Keyword(s):